CA
NZ
UK
AU
IND
US
In the October update, Arqit guided full-year fiscal 2026 revenue, for the year ended September 30, 2026, to USD 975,000 to USD 1.0 million, up from USD 530,000. Second-half revenue was a weaker USD 355,000 to USD 380,000, against USD 463,000, because recognition under …
Cryoport provides temperature-controlled logistics, storage and related services for cell and gene therapies, where products must stay frozen in transit. It supports 23 commercial therapies and a record 788 clinical trials, according to the release. BioLogistics Solutions grew 16% to USD 22.5 million, and …
CG Oncology develops cretostimogene, an oncolytic immunotherapy delivered into the bladder, for non-muscle invasive bladder cancer. After PIVOT-006, the company expects 12-month data in December 2026 from BOND-003 Cohort P, in BCG-unresponsive papillary-only disease, and from CORE-008 Cohort CX. It also expects to complete …
Fulgent runs a laboratory servicesBusinessand a therapeutic development business. The CFO attributed the quarter to improved collection rates and progress on a billing system issue, and management credited disciplined spending for a better non-GAAP loss outlook. Full-year revenue guidance was held at USD 330 …
Data I/O Corporation filed a current report on November 6, 2026, disclosing that on November 3, 2026, the company issued a press release announcing the appointment of Douglas Adams as Senior Vice President of Global Services, Support and Quality.
Weyco Group, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 6, 2026, reporting third-quarter and nine-month financial results for the period.
Michael Quenzer, EVP and Chief Financial Officer of Lennox International Inc, filed a Form 4 on November 6, 2026, disclosing transactions in Lennox common stock and stock appreciation rights dated November 5, 2026.
Winchester Bancorp, Inc./MD/ (NASDAQ:WSBK) director John Ingalls Snow III filed a Form 4 on November 6, 2026, disclosing the acquisition of restricted stock and stock options on November 4, 2026.
Lincoln National Corp officer James Reid filed a Form 144 notice of proposed sale on November 6, 2026, covering 52,434 shares of Lincoln National common stock to be sold through UBS Financial Services Inc on the New York Stock Exchange.
Director Sara Perkins Salehpour of Winchester Bancorp, Inc./MD/ filed a Form 4 on November 6, 2026, disclosing the acquisition of restricted stock and stock options in Winchester Bancorp common stock on November 4, 2026, as reported on NASDAQ:WSBK.
Please wait processing your request...